Literature DB >> 21426455

Onset features and subsequent clinical evolution of childhood diabetes over several years.

Rebecca B Lipton1, Melinda L Drum, Kirstie K Danielson, Siri Aw Greeley, Graeme I Bell, William A Hagopian.   

Abstract

AIM: To explore whether it is possible to predict a child's eventual diabetes phenotype using characteristics at initial presentation, we reassessed 111 young patients on average 7.8 ± 4.2 (2.2-19.7) [mean ± SD (range)] years after diagnosis.
METHODS: Medical records at diagnosis for 111 patients, aged 0-17, were compared with their follow-up characteristics including stimulated C-peptide (CP) and islet autoantibodies (AB).
RESULTS: Initially, 18 patients were obese; 9 displayed other type 2 diabetes (T2DM) features (polycystic ovary syndrome, acanthosis, diagnosed T2DM); the remaining 84 had a classic type 1 diabetes (T1DM) presentation. At follow-up, 83 patients (75%) with no measured CP were classified as T1DM; 17 (15%) were CP+ and AB- and thus considered T2DM. Eleven patients with both T1DM and T2DM features were classified as having mixed diabetes phenotype (MDM). One-fifth (22 subjects) changed presumed phenotype at follow-up. In multivariable models, T1DM patients were younger at diagnosis, had higher initial glucose values, were more likely to have experienced ketoacidosis, and less likely to be obese or of African American ethnicity. CONCLUSIONS/
INTERPRETATION: Ten percent of subjects had MDM and 15% had T2DM at ∼8 years' duration. Although no onset feature was completely reliable, ketoacidosis and hyperglycemia were more likely to predict T1DM; obesity and African American ethnicity made T2DM more likely. At diagnosis, features of T2DM in addition to obesity were strongly predictive of eventual T2DM phenotype. Given the significant percentage who changed or had mixed phenotype, careful tracking of all young people with diabetes is essential to correctly determine eventual disease type.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21426455      PMCID: PMC3103597          DOI: 10.1111/j.1399-5448.2010.00706.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  20 in total

1.  Temporal changes in the frequencies of HLA genotypes in patients with Type 1 diabetes--indication of an increased environmental pressure?

Authors:  R Hermann; M Knip; R Veijola; O Simell; A-P Laine; H K Akerblom; P-H Groop; C Forsblom; K Pettersson-Fernholm; J Ilonen
Journal:  Diabetologia       Date:  2003-03-18       Impact factor: 10.122

2.  Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients.

Authors:  E Cagliero; E V Levina; D M Nathan
Journal:  Diabetes Care       Date:  1999-11       Impact factor: 19.112

3.  Prognostic factors for the course of beta cell function in autoimmune diabetes.

Authors:  C Törn; M Landin-Olsson; A Lernmark; J P Palmer; H J Arnqvist; G Blohmé; F Lithner; B Littorin; L Nyström; B Scherstén; G Sundkvist; L Wibell; J Ostman
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

Review 4.  The accelerator hypothesis: weight gain as the missing link between Type I and Type II diabetes.

Authors:  T J Wilkin
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

5.  Random C-peptide in the classification of diabetes.

Authors:  B Berger; G Stenström; G Sundkvist
Journal:  Scand J Clin Lab Invest       Date:  2000-12       Impact factor: 1.713

6.  Obesity, increased linear growth, and risk of type 1 diabetes in children.

Authors:  E Hyppönen; S M Virtanen; M G Kenward; M Knip; H K Akerblom
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

7.  Evidence for heterogeneous pathogenesis of insulin-treated diabetes in black and white children.

Authors:  Ingrid M Libman; Massimo Pietropaolo; Silva A Arslanian; Ronald E LaPorte; Dorothy J Becker
Journal:  Diabetes Care       Date:  2003-10       Impact factor: 19.112

8.  Hospitalization subsequent to diagnosis in young patients with diabetes in Chicago, Illinois.

Authors:  Carmela L Estrada; Kirstie K Danielson; Melinda L Drum; Rebecca B Lipton
Journal:  Pediatrics       Date:  2009-08-10       Impact factor: 7.124

9.  Characterization of seven C-peptide antisera.

Authors:  O K Faber; C Binder; J Markussen; L G Heding; V K Naithani; H Kuzuya; P Blix; D L Horwitz; A H Rubenstein
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

10.  National Health and Nutrition Examination Survey 1999-2000: effect of observer training and protocol standardization on reducing blood pressure measurement error.

Authors:  Yechiam Ostchega; Ronald J Prineas; Ryne Paulose-Ram; Carlene M Grim; Grace Willard; Doreen Collins
Journal:  J Clin Epidemiol       Date:  2003-08       Impact factor: 6.437

View more
  4 in total

1.  Utility of diabetes-associated autoantibodies for classification of new onset diabetes in children and adolescents.

Authors:  Julia E von Oettingen; Joseph I Wolfsdorf; Henry A Feldman; Erinn T Rhodes
Journal:  Pediatr Diabetes       Date:  2015-08-28       Impact factor: 4.866

2.  Aortic Intima-Media Thickness and Mean Platelet Volume in Children With Type 1 Diabetes Mellitus.

Authors:  Murat Ersoy; Hatice Nilgun Selcuk Duru; Murat Elevli; Ozlem Ersoy; Mahmut Civilibal
Journal:  Iran J Pediatr       Date:  2015-04-18       Impact factor: 0.364

3.  Assessment of hematologic indices and their correlation to hemoglobin A1c among Bosnian children with type 1 diabetes mellitus and their healthy peers.

Authors:  Suzana Tihić-Kapidžić; Adlija Čaušević; Jasmina Fočo-Solak; Maja Malenica; Tanja Dujić; Sniježana Hasanbegović; Nermina Babić; Ermin Begović
Journal:  J Med Biochem       Date:  2021-03-12       Impact factor: 3.402

4.  Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study.

Authors:  David J Pettitt; Jennifer Talton; Dana Dabelea; Jasmin Divers; Giuseppina Imperatore; Jean M Lawrence; Angela D Liese; Barbara Linder; Elizabeth J Mayer-Davis; Catherine Pihoker; Sharon H Saydah; Debra A Standiford; Richard F Hamman
Journal:  Diabetes Care       Date:  2013-09-16       Impact factor: 19.112

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.